Don't stop at statins: complementary PCSK9 use in patients at high risk for recurrent cardiac events

Eur Heart J Qual Care Clin Outcomes. 2019 Jul 1;5(3):193-194. doi: 10.1093/ehjqcco/qcz013.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cardiovascular Diseases*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Proprotein Convertase 9
  • Sweden

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • PCSK9 protein, human
  • Proprotein Convertase 9